Friday, November 22, 2024
HomeTagsNGS

Tag: NGS

spot_imgspot_img

Massive Bio & Foundation Medicine Enhance Trial Recruitment

Massive Bio, a cutting-edge AI driven clinical trial matching platform provider, and Foundation Medicine, Inc. announced a strategic collaboration to increase patient access to...

QIAGEN’s software QCI Interpret accelerates clinical reporting turnaround time for high throughput NGS testing labs

QIAGEN announced the release of a new version of its clinical decision support software, QIAGEN Clinical Insight Interpret (QCI Interpret), that brings significant performance...

SOPHiA GENETICS Announces Kepler Uniklinikum is Live on SOPHiA DDM™ Platform

SOPHiA GENETICS, a cloud-native healthcare technology company and a leader in data-driven medicine, announced that Kepler Uniklinikum, Austria's second largest hospital, is live on...

Massive Bio and Mika Health Combine AI and Next-Generation Sequencing Biomarker Testing to Empower Cancer Patients On Treatment and Those Searching for and Participating...

Massive Bio, a renowned leader in AI-driven oncology solutions and Mika Health, the premier oncology digital therapeutic platform, announced a partnership to significantly expand patient...

QIAGEN enhances bioinformatics workflows with new secondary analysis solution for oncology and inherited disease applications

QIAGEN announced the availability of QCI Secondary Analysis, a cloud-based software-as-a-services (SaaS) solution enabling high-throughput secondary analysis for use with any clinical next-generation sequencing...

InterVenn Biosciences Welcomes Accomplished Diagnostics Executive Joshua Stahl as CEO

Stahl will leverage proven experience in building innovative diagnostic organizations to accelerate InterVenn’s commercialization efforts. InterVenn Biosciences, the life sciences company pioneering glycoproteomic-based diagnostics, announced...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

[tds_leads input_placeholder=”Your email address” btn_horiz_align=”content-horiz-center” pp_msg=”SSd2ZSUyMHJlYWQlMjBhbmQlMjBhY2NlcHQlMjB0aGUlMjAlM0NhJTIwaHJlZiUzRCUyMiUyMyUyMiUzRVByaXZhY3klMjBQb2xpY3klM0MlMkZhJTNFLg==” pp_checkbox=”yes” tdc_css=”eyJhbGwiOnsibWFyZ2luLXRvcCI6IjMwIiwibWFyZ2luLWJvdHRvbSI6IjQwIiwiZGlzcGxheSI6IiJ9LCJwb3J0cmFpdCI6eyJtYXJnaW4tdG9wIjoiMTUiLCJtYXJnaW4tYm90dG9tIjoiMjUiLCJkaXNwbGF5IjoiIn0sInBvcnRyYWl0X21heF93aWR0aCI6MTAxOCwicG9ydHJhaXRfbWluX3dpZHRoIjo3NjgsImxhbmRzY2FwZSI6eyJtYXJnaW4tdG9wIjoiMjAiLCJtYXJnaW4tYm90dG9tIjoiMzAiLCJkaXNwbGF5IjoiIn0sImxhbmRzY2FwZV9tYXhfd2lkdGgiOjExNDAsImxhbmRzY2FwZV9taW5fd2lkdGgiOjEwMTksInBob25lIjp7Im1hcmdpbi10b3AiOiIyMCIsImRpc3BsYXkiOiIifSwicGhvbmVfbWF4X3dpZHRoIjo3Njd9″ display=”column” gap=”eyJhbGwiOiIyMCIsInBvcnRyYWl0IjoiMTAiLCJsYW5kc2NhcGUiOiIxNSJ9″ f_msg_font_family=”downtown-sans-serif-font_global” f_input_font_family=”downtown-sans-serif-font_global” f_btn_font_family=”downtown-sans-serif-font_global” f_pp_font_family=”downtown-serif-font_global” f_pp_font_size=”eyJhbGwiOiIxNSIsInBvcnRyYWl0IjoiMTEifQ==” f_btn_font_weight=”700″ f_btn_font_size=”eyJhbGwiOiIxMyIsInBvcnRyYWl0IjoiMTEifQ==” f_btn_font_transform=”uppercase” btn_text=”Unlock All” btn_bg=”#000000″ btn_padd=”eyJhbGwiOiIxOCIsImxhbmRzY2FwZSI6IjE0IiwicG9ydHJhaXQiOiIxNCJ9″ input_padd=”eyJhbGwiOiIxNSIsImxhbmRzY2FwZSI6IjEyIiwicG9ydHJhaXQiOiIxMCJ9″ pp_check_color_a=”#000000″ f_pp_font_weight=”600″ pp_check_square=”#000000″ msg_composer=”” pp_check_color=”rgba(0,0,0,0.56)” msg_succ_radius=”0″ msg_err_radius=”0″ input_border=”1″ f_unsub_font_family=”downtown-sans-serif-font_global” f_msg_font_size=”eyJhbGwiOiIxMyIsInBvcnRyYWl0IjoiMTIifQ==” f_input_font_size=”eyJhbGwiOiIxNCIsInBvcnRyYWl0IjoiMTIifQ==” f_input_font_weight=”500″ f_msg_font_weight=”500″ f_unsub_font_weight=”500″]

Must read

spot_img